-
Taxonomy & unit
-
us-gaap: CNY and USD
-
Description
-
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
-
Summary
-
Gracell Biotechnologies Inc. quarterly Liabilities and Equity history and growth rate from Q4 2020 to Q2 2023.
- Gracell Biotechnologies Inc. Liabilities and Equity for the quarter ending June 30, 2023 was $190M, a 33% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)